Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Anti-Corruption, Compliance Scrutiny Increase In Emerging Markets

This article was originally published in The Pink Sheet Daily

Executive Summary

In the next few years, the Department of Justice's enforcement focus will be the Foreign Corrupt Practices Act and its application to the pharmaceutical industry, DoJ official says.

You may also be interested in...



Overseas Contractor Bill Could Give Pharma Federal Contracting Headaches In U.S.

A U.S. House-passed bill that would bar firms from federal contracts if they violate the Foreign Corrupt Practices Act could put any violative pharma firms at risk of losing participation in drug benefit programs with the Department of Veterans Affairs, Medicaid and Medicare

Overseas Contractor Bill Could Give Pharma Federal Contracting Headaches In U.S.

House bill would bar firms in violation of the Foreign Corrupt Practices Act from federal contracts or grants.

Overseas Contractor Bill Could Give Pharma Federal Contracting Headaches In U.S.

House bill would bar firms in violation of the Foreign Corrupt Practices Act from federal contracts or grants.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS070754

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel